Connection

Kamlesh Khunti to Glucagon-Like Peptide 1

This is a "connection" page, showing publications Kamlesh Khunti has written about Glucagon-Like Peptide 1.
Connection Strength

0.522
  1. A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial. Diabetes Obes Metab. 2014 Jun; 16(6):527-36.
    View in: PubMed
    Score: 0.522
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.